Cholesterol-lowering medications are also an important part of treatment for many people with elevated blood lipid levels.
降胆固醇药物对许多血脂水平升高的人来说，也是治疗的一个重要部分。
Methods: 85 cases of type 2 DM complicated with blood - lipid disorder were allocated to treatment group (57 cases) and control group (28 cases) randomly.
方法：将85例2型糖尿病合并血脂异常患者随机分为治疗组57例和对照组28例。
Results: the blood - lipid disorder and insulin sensitivity were markedly improved in the treatment group.
结果：治疗组血脂异常和胰岛素敏感性均有明显改善。
The effects of ultra-high pressure treatment on color, texture, oxidation of lipid, freezing and thawing process of meats were introduced in this paper.
介绍了以超高压处理时，超高压对肉的颜色、肉的组织结构、肉中脂肪的氧化、肉的冻结过程和解冻过程的影响。
Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis.
异柠檬酸脱氢酶，其基因，以及其在肥胖、高脂血症、和脂肪肝治疗和在脂类生物合成中的用途。
OBJECTIVE:To observe the curative effect of Piperazine Ferulate Tablets in treatment of lipid metabolism disorders secondary to nephritic syndrome.
目的：观察阿魏酸哌嗪片治疗肾病综合征继发脂质代谢紊乱的疗效。
This article reviewed the classification of hyperlipidemias, the blood lipid desirable level and current treatment guide-lines, and discussed lipid regulators and unresolved issues.
对血脂化验的参考值、高脂血症的分类、调脂治疗原则、调脂药物及其合理应用和尚待解决的问题作了回顾与展望。
Objective To observe the regulatory effect of non-pharmaceutical treatment on lipid profile in patients with dyslipidemia.
目的观察非药物治疗对血脂异常患者的调脂效果。
The results give evidence that Al treatment caused oxidative stress and in turn, it caused lipid peroxidation.
这个结果显示，导致氧化应激和铝处理，它导致脂质过氧化作用。
Before and after treatment, some indexes were observed including clinical symptoms, FBG, 2HPG in OGTT, INS, lipid, blood rheology , BMI, IR, IAI etc.
治疗前后分别观察临床症状、空腹及餐后2h血糖和胰岛素、糖基化血红蛋白、血脂、血流变学、BMI、IR、IAI等指标。
The effects of zinc gluconate on the lipid peroxidation and the activity of antioxidase in silicosis rats with preventive treatment and the treatment after being exposed to dust are reported.
本文报告了葡萄糖酸锌，对矽肺大鼠预防性治疗和病后治疗脂质过氧化及抗氧化酶活性的影响。
Benefit-risk profile of lipid-lowering medicines continues to be positive, but first-line treatment is not recommended.
对于降血脂药物的效益风险预测目前仍然显示积极的结果，但已不推荐作为一线用药。
As NRs play major roles in the regulation of lipid metabolism, glucose homeostasis, and inflammatory processes, they are considered as ideal targets for the treatment of cardiovascular diseases.
由于核受体在调节脂质代谢、糖代谢以及炎症反应方面发挥重要作用，它们是治疗心血管疾病理想的靶标。
The changes of blood lipid and IMT were observed before and after treatment.
观察两组治疗前后血脂和颈动脉内-中膜厚度变化。
The conclusion was that the intermittent hypoxic exercise strengthened the metabolism of lipid and had certain function for cardiovascular disease treatment.
结论：间歇低氧运动可加强机体脂质代谢过程，并对心血管疾病治疗有一定的作用。
Results:The FPG and blood lipid decreased obviously after the treatment, the total effective rate was 84.37%.
结果：治疗前后比较，以空腹血糖和血脂水平的改善尤为显著，总有效率为84.37%。
Additionally, patients visited the clinic at one, three and six months following start of treatment. At each visit, BMI, blood pressure, lipid profile and total antioxidant status were recorded.
除此之外，病人在实验开始后的第一个月、第三个月和第六个月到医院复查。每次检查都会记录病人的BMI、血压、血脂水平、和整体抗氧化水平。
Conclusions Patients have a good tolerance, good effects and can keep continuous qualified serum lipid level after maintaining treatment with low dosage of simvastatin.
结论辛伐他汀低剂量维持治疗，患者耐受性好，疗效确切，能保持血脂水平持续达标。
Conclusions Clozapine treatment may cause abnormal blood-lipid level and then myocardial damage, but no weight gain in short term.
结论氯氮平治疗可引起血脂异常，且血脂异常可能和心肌损伤有关，但短期内未见与体重增加有关。
AIM: to investigate the risk factors and clinical significance of blood-lipid metabolic disorder in schizophrenic patients caused by phenothiazine treatment for long term (from 1 month to 25 years).
目的：探讨长时间(1月- 25年)接受酚噻嗪类药物治疗后的精神分裂症患者引起血脂代谢紊乱的危险因素及其临床意义。
The changes of blood rheology and blood-lipid indexes were observed before and after treatment.
观察治疗前后血液流变学及血脂等指标的变化。
This article reviews the relationship between lipids and stroke, as well as the role of lipid-modulating therapy in the prevention and treatment of stroke.
文章对血脂与卒中的关系以及调脂治疗在卒中预防和治疗中的作用进行综述。
Blood pressure, renal function, blood lipid were detected before and after treatment and evaluation of the effect and adverse reactions.
监测治疗前后血压、肾功能、血脂，评价降压疗效，记录不良反应。
Fasting blood glucose, blood lipid, blood creatinine, uric acid, blood potassium, blood natrium and blood chlorine, were examined before and after 2 months treatment.
治疗前和治疗后2个月后分别检测空腹血糖，血脂，血尿酸，血肌酐，血钾、钠和氯。
Conclusion: in the rise of blood lipid and the abnormality of liver function, the treatment of the fatty liver patients can be given liver -protecting and fat -lowing drugs.
结论：在血脂升高合并肝功能异常时，应采取以保肝加降脂功能为主的药物治疗措施。
There were no significant changes in blood routine, routine urine examination, blood sugar, blood lipid, liver function, renal function and ECG of two groups after treatment(P>0.05).
两组治疗前后血尿常规、血糖、血脂、肝功、肾功、心电图均无明显改变（P>0.05）。
There were no significant changes in blood routine, routine urine examination, blood sugar, blood lipid, liver function, renal function and ECG of two groups after treatment(P>0.05).
两组治疗前后血尿常规、血糖、血脂、肝功、肾功、心电图均无明显改变（P>0.05）。
应用推荐